Egress Group reposted this
Early identification of potential risk of disease is a game-changer for our health service, individuals and their families. Outcomes are being significantly improved for 1000s of people like John with timelier, preventative (and also more cost-effective) care. Thanks for sharing this story Predictive Health Intelligence, one which we are delighted to have played a part in as co-developers of HepatoSIGHT – the data-driven, case-finding search engine supporting clinicians to proactively identify people with liver disease earlier. Looking forward to hearing more patient perspectives over the coming weeks. #FutureOfHealth #PreventativeCare #DataDrivingInnovation
The Patient Perspective 🤒 At Predictive Health Intelligence, our mission is to help end the late diagnosis of liver disease. That’s why we created hepatoSIGHT – a case-finding search engine designed to help clinicians make better use of historical medical data to proactively identify people with liver disease earlier. John, a retired NHS worker in his late 60s, is one of the many individuals who have benefitted from hepatoSIGHT, and he wanted to share his story. Like many people, John had undergone regular blood tests over the years with no worrying results. Having recently made some positive lifestyle changes, such as giving up drinking, he felt confident about his health. However, when doctors using hepatoSIGHT saw something unusual in his past tests, John received a letter from Somerset NHS Foundation Trust inviting him to clinic so they could take a closer look at his liver health. After further blood tests and a consultation with doctors at Somerset NHS Foundation Trust, it was suspected that John might have metabolic-related liver disease, a common and often benign condition but one that can progress to advanced liver diseases like cirrhosis and liver cancer if left unchecked. An ultrasound-based non-invasive test called a FibroScan confirmed the diagnosis, but due to the analysis provided by hepatoSIGHT, it had been caught relatively early. John received advice on how to prevent his condition worsening, and will benefit from annual monitoring just in case things do progress. To others who might receive a similar letter, John’s message is simple: “Don’t panic! It’s always good to investigate what’s going on. When there are expert people prepared to try and help, you should take them up on it.” This is just one of many stories where hepatoSIGHT has helped clinicians uncover liver disease early, allowing for timely, preventative, and cost-effective care. Stay tuned over the coming weeks to learn more about our impact, one patient at a time. #LiverHealth #PatientEngagement #PublicHealth
Thanks for resharing Stalis and for all your support that has enabled these improvements to care.